A ketogenic diet in combination with gemcitabine increases survival in pancreatic cancer KPC mice.

Cancer Res Commun · 2022 · PMC9648418 · PMID 36382086

Europe PMC DOI

hedged sentence

0.0520

closest p · 1.0× alpha

0.0520

boldest claim

The sentences

a trend toward significanceP = 0.052so close (0.05 < p ≤ 0.1)

As shown in Table 1 , gemcitabine significantly extended mean survival by 25.8 days ( P = 0.002), KD extended mean survival by 13.8 days with a trend toward significance ( P = 0.052).

also in 3,729 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.